Trump announces plan to lower the cost of a common IVF drug

A groundbreaking HIV protection jab has been approved in England and Wales, offering a new alternative to daily pills. This innovative shot, administered six times a year or every other month, represents a significant advancement in the fight against HIV, making it easier for individuals to protect themselves from the virus. This approval is crucial as it could lead to increased adherence to prevention methods and ultimately reduce the spread of HIV.

A grandfather from Wichita, KS, recently fought for coverage of his spinal surgery after being denied multiple times. Inspired by the NBC News series 'The Cost of Denial,' he reached out to the network for help. Following their inquiry to his insurance company, his surgery was finally approved. This story highlights the importance of advocacy in healthcare and the impact media can have on individual cases.

President Donald Trump has unveiled a new initiative aimed at making fertility treatments more affordable by partnering with the manufacturer of a widely used IVF drug. This deal will allow consumers to purchase these medications at a discounted rate through the TrumpRx website. This move is significant as it addresses the financial barriers many face when seeking fertility assistance, potentially making these essential treatments more accessible to those in need.

On October 23, nutrition expert Kevin Hall will engage with WSJ reporters in a live chat to answer your questions about healthy eating, ultraprocessed foods, and diet. This interactive session is a great opportunity for WSJ subscribers to gain insights directly from experts, making it easier to navigate the complexities of nutrition and improve personal health choices.

Diane Keaton, the beloved Oscar-winning actress, has sadly passed away due to pneumonia, as confirmed by her family in a statement to People magazine. This news is significant as it highlights the serious nature of pneumonia, a lung infection that can affect anyone, and serves as a reminder of the importance of health awareness.

California is set to launch its own brand of affordable insulin starting January 1, a move announced by Governor Gavin Newsom nearly three years ago. This initiative aims to provide a more accessible option for those who rely on insulin, addressing the rising costs of diabetes management. By offering state-branded generic drugs at lower prices, California is taking a significant step towards improving healthcare affordability, which is crucial for many families struggling with medical expenses.